IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR ENOXAPARIN BIOSIMILARS (INHIXA and AROVI)

· London and South East Regional Medicines Information

This UKMi Product Safety assessment on Inhixa and Arovi (enoxaparin biosimilars) describes the in-use medication safety considerations resultant from the products’ presentation or other pre-defined characteristics. Potential next steps and mitigation actions are suggested. It has been produced using the validated UKMi product assessment tool.

Cardiovascular system disordersEnoxaparinHaematological disordersMedicines SafetyNews

Attachments